Infectious Diseases and Therapy
@InfectDis_Ther
Followers
2K
Following
287
Media
532
Statuses
1K
PubMed-indexed, rapid publication, peer reviewed #openaccess journal. Impact Factor 4.7. CiteScore 8.6. Part of @AdisJournals.
Chester, England
Joined July 2017
Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis. Read the full article here:
link.springer.com
Infectious Diseases and Therapy - Health claims data are a valuable resource for health services research, enabling analysis of the costs of hospitalizations, outpatient visits, procedures, and...
0
0
0
Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis. Read the full article here:
link.springer.com
Infectious Diseases and Therapy - There remains uncertainty about whether transitioning to oral antibiotic therapy is appropriate for the management of children with methicillin-resistant...
0
1
0
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults. Read the full article here: https://t.co/cYXDPeYc9c
0
0
0
Our latest review explores the characteristics and uses of endolysins derived from staphylococcal bacteriophages, as well as their antibacterial effectiveness against Staphylococcus spp. Read the full article here:
link.springer.com
Infectious Diseases and Therapy - Antimicrobial resistance is a significant global public health issue, and the dissemination of antibiotic resistance in Gram-positive bacterial pathogens has...
0
0
0
COVID-19 Vaccination Recommendations for Immunocompromised Patient Populations: Delphi Panel and Consensus Statement Generation in the United States #COVIDー19 Read the full article #OpenAccess here: https://t.co/OcNGYTXDUn
0
0
0
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients #COVIDー19 Read the full article #openaccess here: https://t.co/IGPnUl5sE7
0
0
0
Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19:
0
0
0
This study, just published in Infectious Diseases and Therapy, evaluated the value-based price of the RSVpreF vaccine for pregnant people used for prevention of RSV-LRTI among infants in Argentina:
link.springer.com
Infectious Diseases and Therapy - Lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV) is common among young children in Argentina. Use of the currently available...
0
0
0
Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?
link.springer.com
Infectious Diseases and Therapy - The spread of carbapenemase-producing gram-negative pathogens, especially those producing metallo-β-lactamases (MBLs), has become a major health concern. MBLs...
0
1
0
Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort Study:
link.springer.com
Infectious Diseases and Therapy - International guidelines recommend definitive combination antibiotic therapy for the management of serious infections involving carbapenem-resistant Acinetobacter...
0
3
5
Acute Cerebellitis Following COVID-19: Alarming Clinical Presentation Challenged by Normal Paraclinical Findings:
link.springer.com
Infectious Diseases and Therapy - We report the case of an acute cerebellitis following COVID-19 in 32-year-old man who presented with a life-threatening critical cerebellar syndrome contrasting...
0
0
0
Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018:
0
0
0
Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes https://t.co/78gIPhPL9l
0
0
0
Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19:
0
0
0
Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review:
link.springer.com
Infectious Diseases and Therapy - Mycoplasma hominis can be a part of human urogenital tract microbiome, and it is a frequent cause of urogenital infections. In rare cases, it can also cause...
0
0
0
The latest piece of research published in Infectious Diseases and Therapy looked at the extracorporeal removal of cytokines from the bloodstream, and the potential of this therapy to help in treating septic shock. More here:
link.springer.com
Infectious Diseases and Therapy - The release of pro-inflammatory cytokines in critically ill patients with sepsis leads to endothelial dysfunction resulting in cardiocirculatory insufficiency....
0
1
3
New research just published in Infectious Diseases and Therapy describes a model which estimated the cost benefits of using the antiviral drug baloxavir, compared to oseltamivir or no treatment for #influenza patients. https://t.co/gXwY5p1hdu
link.springer.com
Infectious Diseases and Therapy - This study sought to evaluate the cost-effectiveness of baloxavir marboxil compared with oseltamivir or no antiviral treatment from a US payer perspective using...
0
0
0
How do we define long-COVID for better research, diagnostics and treatment? In this commentary, just published in Infectious Diseases & Therapy, the authors propose refinement into three sub-groups - read more here: https://t.co/foPgtazAf0
link.springer.com
Infectious Diseases and Therapy - The term long COVID (LC) effectively describes the broad long-term disease burden of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections,...
0
7
26
"#Safety, #Tolerability, and #Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers" https://t.co/vGoN2I87nd
#RespiratorySyncytialVirus #RSV
0
1
2
"Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions" Available #openaccess here: https://t.co/UXqA8BihDO
#covid19 #infectiousdiseases
0
0
0